Search Results
Overview of CAR-T Cells and Toxicities - N. Grover and F. B. Buchanan - 20210526
The Science and Ethics of CAR T-Cell Therapies
Transplant and CAR-T for relapsed MCL
CD30, a promising target for CAR-T therapy in Hodgkin lymphoma
16-June-2021 AATM Cellular Therapies Working Group Webinar CAR T Cells Part 1
12-17-20 - Cellular Therapy for Cancer: From TIL to CAR-T
Upcoming regimens in MCL
The role of transplant in MCL in the era of cellular therapy
Imugene + Celularity Announce an Exclusive Strategic Partnership to Develop a Novel Oncolytic Virus.
MonumenTAL-1: updated data on talquetamab in R/R myeloma
INSIGHT-MM: real-world analysis of DOT with Rd-based regimens in R/R myeloma
MYELOMA TRIALS EXPLAINED: Mass Accumulation Rate as a Predictive Biomarker for Treatment Selection
